Hzymes

"Hzymes" Each Molecule Promises Accuracy }
Development History – Hzymes Biotech }

Hzymes Development History

2022
2021
2020
2019
2018
2017
2016
2015
2022

1/621 Hzymes ranked in the 2022 Hurun Global Gazelle Enterprise Ranking;

1/4357 Hzymes won the title of "Little Giant" at the national level;

2022.10.17 Hzymes Open new Office Park;

2021

Strategic investment in Renxin Biotechnology, extending to innovative application platforms

In March, the Institute of Key Raw Materials of Shanghai Institute of Experimental Medicine was jointly established; it became the vice president unit of CAIVD; Proteinase K won the annual innovative excellent product of China in vitro diagnostics

2020

2020.03 - Shanghai Fengchuanggu R&D and marketing center completed

2020.04-Full-scale entry into the field of molecular diagnostics

The company's sales exceeded 100 millions yuan; the cumulative external financing exceeded 100 millions yuan

Won the title of "China Unicorn Enterprise" in 2020

The technical team of the new crown emergency project won the "Jiangsu Youth May 4th Medal Collective"

2019

2019.04 - Participated in Wuhan Sugarwise Pharmaceuticals, formally entered the enzyme synthesis drugs industry

2019.7 - Received million RMB Series A investment from Tianhui Sumin Investment and Zhonafu Yide

2019.12 - Annual sales of over 35 million

2018

2018.05 - Completed the raw material chapter of the China Medical Device Blue Book

2018 - First half of the year Enter the field of chemiluminescence diagnostics, alkaline phosphatase substrate online

2018.07 _ Wuhan 1200 square meters GMP plant completed

2017

2017 03 - Large scale trial of products to end customers

2017.08 - Received 5 million angel round investment from Wuhan Hanying

9017 09 _ ISO 900 quality management system certification

2017.10 - Received 15 million RMB Pre.A round of investment from Naning Huituo and Sanze Venture Capital

2016

2016 - Switching to IVD field, developing glycated hemoglobin and other products

2016 11 - Received $1.25 million seed round investment

2015

2015.01 - Hymes Established in Wuhan

2015.06 - Development of drug-catalyzed enzymes begins. but does not progress well

2015.12 - Awarded the "3551" talent plan proiect. received 2 million government guidance fund.